On December 23, 2022, Gov. Hochul signed into law Assembly Bill No. 372, which amends the insurance laws to prohibit copayments during treatment at an opioid treatment program.
Under the amendment, every policy that provides coverage for treatment at an opioid treatment program cannot impose a copayment fee during treatment on any insured for such treatment. An “opioid treatment program” is defined as a program or practitioner engaged in opioid treatment of individuals with an opioid agonist treatment medication.
Employers that sponsor insured plans should be aware of this amendment, which is effective January 1, 2023, and applies to group and individual policies and contracts issued, renewed, modified, altered or amended on and after such date.
Assembly Bill 372 »
PPI Benefit Solutions does not provide legal or tax advice. Compliance, regulatory and related content is for general informational purposes and is not guaranteed to be accurate or complete. You should consult an attorney or tax professional regarding the application or potential implications of laws, regulations or policies to your specific circumstances.
Subscribe